Björn Buchholz
University of Erlangen-Nuremberg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Björn Buchholz.
Journal of Immunology | 2008
Jonathan Jantsch; Dipshikha Chakravortty; Nadine Turza; Alexander T. Prechtel; Björn Buchholz; Roman G. Gerlach; Melanie Volke; Joachim Gläsner; Christina Warnecke; Michael S. Wiesener; Kai-Uwe Eckardt; Alexander Steinkasserer; Michael Hensel; Carsten Willam
Dendritic cells (DC) play a key role in linking innate and adaptive immunity. In inflamed tissues, where DC become activated, oxygen tensions are usually low. Although hypoxia is increasingly recognized as an important determinant of cellular functions, the consequences of hypoxia and the role of one of the key players in hypoxic gene regulation, the transcription factor hypoxia inducible factor 1α (HIF-1α), are largely unknown. Thus, we investigated the effects of hypoxia and HIF-1α on murine DC activation and function in the presence or absence of an exogenous inflammatory stimulus. Hypoxia alone did not activate murine DC, but hypoxia combined with LPS led to marked increases in expression of costimulatory molecules, proinflammatory cytokine synthesis, and induction of allogeneic lymphocyte proliferation compared with LPS alone. This DC activation was accompanied by accumulation of HIF-1α protein levels, induction of glycolytic HIF target genes, and enhanced glycolytic activity. Using RNA interference techniques, knockdown of HIF-1α significantly reduced glucose use in DC, inhibited maturation, and led to an impaired capability to stimulate allogeneic T cells. Alltogether, our data indicate that HIF-1α and hypoxia play a crucial role for DC activation in inflammatory states, which is highly dependent on glycolysis even in the presence of oxygen.
The EMBO Journal | 2005
Michael Köttgen; Thomas Benzing; Thomas Simmen; Robert Tauber; Björn Buchholz; Sylvain F. Feliciangeli; Tobias B. Huber; Bernhard Schermer; Albrecht Kramer-Zucker; Katja Höpker; Katia Carmine Simmen; Christoph Carl Tschucke; Richard Sandford; Emily Kim; Gary Thomas; Gerd Walz
The trafficking of ion channels to the plasma membrane is tightly controlled to ensure the proper regulation of intracellular ion homeostasis and signal transduction. Mutations of polycystin‐2, a member of the TRP family of cation channels, cause autosomal dominant polycystic kidney disease, a disorder characterized by renal cysts and progressive renal failure. Polycystin‐2 functions as a calcium‐permeable nonselective cation channel; however, it is disputed whether polycystin‐2 resides and acts at the plasma membrane or endoplasmic reticulum (ER). We show that the subcellular localization and function of polycystin‐2 are directed by phosphofurin acidic cluster sorting protein (PACS)‐1 and PACS‐2, two adaptor proteins that recognize an acidic cluster in the carboxy‐terminal domain of polycystin‐2. Binding to these adaptor proteins is regulated by the phosphorylation of polycystin‐2 by the protein kinase casein kinase 2, required for the routing of polycystin‐2 between ER, Golgi and plasma membrane compartments. Our paradigm that polycystin‐2 is sorted to and active at both ER and plasma membrane reconciles the previously incongruent views of its localization and function. Furthermore, PACS proteins may represent a novel molecular mechanism for ion channel trafficking, directing acidic cluster‐containing ion channels to distinct subcellular compartments.
Journal of The American Society of Nephrology | 2008
Alexander Weidemann; Wanja M. Bernhardt; Bernd Klanke; Christoph Daniel; Björn Buchholz; Valentina Câmpean; Kerstin Amann; Christina Warnecke; Michael S. Wiesener; Kai-Uwe Eckardt; Carsten Willam
The contribution of hypoxia to cisplatin-induced renal tubular injury is controversial. Because the hypoxia-inducible factor (HIF) pathway is a master regulator of adaptation to hypoxia, we measured the effects of cisplatin on HIF accumulation in vitro and in vivo, and tested whether hypoxic preconditioning is protective against cisplatin-induced injury. We found that cisplatin did not stabilize HIF-1alpha protein in vitro or in vivo under normoxic conditions. However, hypoxic preconditioning of cisplatin-treated proximal tubular cells in culture reduced apoptosis in an HIF-1alpha-dependent fashion and increased cell proliferation as measured by BrdU incorporation. In vivo, rats preconditioned with carbon monoxide before cisplatin administration had significantly better renal function than rats kept in normoxic conditions throughout. Moreover, the histomorphological extent of renal damage and tubular apoptosis was reduced by the preconditional treatment. Therefore, development of pharmacologic agents to induce renal HIF might provide a new approach to ameliorate cisplatin-induced nephrotoxicity.
Proceedings of the National Academy of Sciences of the United States of America | 2009
Wanja M. Bernhardt; U. Gottmann; F. Doyon; Björn Buchholz; Valentina Campean; Johannes Schödel; A. Reisenbuechler; S. Klaus; M. Arend; L. Flippin; Carsten Willam; Michael S. Wiesener; B. Yard; Christina Warnecke; Kai-Uwe Eckardt
Long-term survival of renal allografts depends on the chronic immune response and is probably influenced by the initial injury caused by ischemia and reperfusion. Hypoxia-inducible transcription factors (HIFs) are essential for adaptation to low oxygen. Normoxic inactivation of HIFs is regulated by oxygen-dependent hydroxylation of specific prolyl-residues by prolyl-hydroxylases (PHDs). Pharmacological inhibition of PHDs results in HIF accumulation with subsequent activation of tissue-protective genes. We examined the effect of donor treatment with a specific PHD inhibitor (FG-4497) on graft function in the Fisher–Lewis rat model of allogenic kidney transplantation (KTx). Orthotopic transplantation of the left donor kidney was performed after 24 h of cold storage. The right kidney was removed at the time of KTx (acute model) or at day 10 (chronic model). Donor animals received a single dose of FG-4497 (40 mg/kg i.v.) or vehicle 6 h before donor nephrectomy. Recipients were followed up for 10 days (acute model) or 24 weeks (chronic model). Donor preconditioning with FG-4497 resulted in HIF accumulation and induction of HIF target genes, which persisted beyond cold storage. It reduced acute renal injury (serum creatinine at day 10: 0.66 ± 0.20 vs. 1.49 ± 1.36 mg/dL; P < 0.05) and early mortality in the acute model and improved long-term survival of recipient animals in the chronic model (mortality at 24 weeks: 3 of 16 vs. 7 of 13 vehicle-treated animals; P < 0.05). In conclusion, pretreatment of organ donors with FG-4497 improves short- and long-term outcomes after allogenic KTx. Inhibition of PHDs appears to be an attractive strategy for organ preservation that deserves clinical evaluation.
The EMBO Journal | 2009
Tomasz Wegierski; Daniel Steffl; Christoph Kopp; Robert Tauber; Björn Buchholz; Roland Nitschke; E. Wolfgang Kuehn; Gerd Walz; Michael Köttgen
Ca2+ is an important signalling molecule that regulates multiple cellular processes, including apoptosis. Although Ca2+ influx through transient receptor potential (TRP) channels in the plasma membrane is known to trigger cell death, the function of intracellular TRP proteins in the regulation of Ca2+‐dependent signalling pathways and apoptosis has remained elusive. Here, we show that TRPP2, the ion channel mutated in autosomal dominant polycystic kidney disease (ADPKD), protects cells from apoptosis by lowering the Ca2+ concentration in the endoplasmic reticulum (ER). ER‐resident TRPP2 counteracts the activity of the sarcoendoplasmic Ca2+ ATPase by increasing the ER Ca2+ permeability. This results in diminished cytosolic and mitochondrial Ca2+ signals upon stimulation of inositol 1,4,5‐trisphosphate receptors and reduces Ca2+ release from the ER in response to apoptotic stimuli. Conversely, knockdown of TRPP2 in renal epithelial cells increases ER Ca2+ release and augments sensitivity to apoptosis. Our findings indicate an important function of ER‐resident TRPP2 in the modulation of intracellular Ca2+ signalling, and provide a molecular mechanism for the increased apoptosis rates in ADPKD upon loss of TRPP2 channel function.
American Journal of Pathology | 2009
Johannes Schödel; Bernd Klanke; Alexander Weidemann; Björn Buchholz; Wanja M. Bernhardt; Marko Bertog; Kerstin Amann; Christoph Korbmacher; Michael S. Wiesener; Christina Warnecke; Armin Kurtz; Kai-Uwe Eckardt; Carsten Willam
Hypoxia-inducible transcription factors (HIFs) play important roles in the response of the kidney to systemic and regional hypoxia. Degradation of HIFs is mediated by three oxygen-dependent HIF-prolyl hydroxylases (PHDs), which have partially overlapping characteristics. Although PHD inhibitors, which can induce HIFs in the presence of oxygen, are already in clinical development, little is known about the expression and regulation of these enzymes in the kidney. Therefore, we investigated the expression levels of the three PHDs in both isolated tubular cells and rat kidneys. All three PHDs were present in the kidney and were expressed predominantly in three different cell populations: (a) in distal convoluted tubules and collecting ducts (PHD1,2,3), (b) in glomerular podocytes (PHD1,3), and (c) in interstitial fibroblasts (PHD1,3). Higher levels of PHDs were found in tubular segments of the inner medulla where oxygen tensions are known to be physiologically low. PHD expression levels were unchanged in HIF-positive tubular and interstitial cells after induction by systemic hypoxia. In rat models of acute renal injury, changes in PHD expression levels were variable; while cisplatin and ischemia/reperfusion led to significant decreases in PHD2 and 3 expression levels, no changes were seen in a model of contrast media-induced nephropathy. These results implicate the non-uniform expression of HIF-regulating enzymes that modify the hypoxic response in the kidney under both regional and temporal conditions.
Journal of The American Society of Nephrology | 2009
Daniel Romaker; Michael Puetz; Sven Teschner; Johannes Donauer; Marcel Geyer; Peter Gerke; Brigitta Rumberger; Bernd Dworniczak; Petra Pennekamp; Björn Buchholz; Hartmut P. H. Neumann; Rajiv Kumar; Joachim Gloy; Kai-Uwe Eckardt; Gerd Walz
Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary disease associated with progressive renal failure. Although cyst growth and compression of surrounding tissue may account for some loss of renal tissue, the other factors contributing to the progressive renal failure in patients with ADPKD are incompletely understood. Here, we report that secreted frizzled-related protein 4 (sFRP4) is upregulated in human ADPKD and in four different animal models of PKD, suggesting that sFRP4 expression is triggered by a common mechanism that underlies cyst formation. Cyst fluid from ADPKD kidneys activated the sFRP4 promoter and induced production of sFRP4 protein in renal tubular epithelial cell lines. Antagonism of the vasopressin 2 receptor blocked both promoter activity and tubular sFRP4 expression. In addition, sFRP4 selectively influenced members of the canonical Wnt signaling cascade and promoted cystogenesis of the zebrafish pronephros. sFRP4 was detected in the urine of both patients and animals with PKD, suggesting that sFRP4 may be a potential biomarker for monitoring the progression of ADPKD. Taken together, these observations suggest a potential role for SFRP4 in the pathogenesis of ADPKD.
The Journal of General Physiology | 2008
Michael Köttgen; Björn Buchholz; Miguel A. Garcia-Gonzalez; Fruzsina Kotsis; Xiao Fu; Mara Doerken; Christopher Boehlke; Daniel Steffl; Robert Tauber; Tomasz Wegierski; Roland Nitschke; Makoto Suzuki; Albrecht Kramer-Zucker; Gregory G. Germino; Terry Watnick; Jean Prenen; Bernd Nilius; E. Wolfgang Kuehn; Gerd Walz
Kottgen et al. 2008. J. Cell Biol. doi:10.1083/jcb.200805124 [OpenUrl][1][Abstract/FREE Full Text][2] [1]: {openurl}?query=rft_id%253Dinfo%253Adoi%252F10.1083%252Fjcb.200805124%26rft_id%253Dinfo%253Apmid%252F18695040%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%
Kidney International | 2017
Isabel N. Schellinger; Nada Cordasic; Julian Panesar; Björn Buchholz; Johannes Jacobi; Andrea Hartner; Bernd Klanke; Joanna Jakubiczka-Smorag; Nicolai Burzlaff; Eva Heinze; Christina Warnecke; Uwe Raaz; Carsten Willam; Philip S. Tsao; Kai-Uwe Eckardt; Kerstin Amann; Karl F. Hilgers
Biochemical and Biophysical Research Communications | 2004
Björn Buchholz; Robert Tauber; Daniel Steffl; Gerd Walz; Michael Köttgen